Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR

Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR

Conditions: Tachycardia Atrial; Atrial Fibrillation; Atrial Flutter With Rapid Ventricular Response
Interventions: Drug: Magnesium Sulfate 2 G; Drug: Magnesium Sulfate 4 G; Drug: Saline
Sponsors: Aurora Health Care
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 23, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments